lactic acid has been researched along with Communicable Diseases in 9 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigated the prognostic value of the albumin-to-fibrinogen ratio (AFR) in patients with sepsis as a consequence of infection at various sites." | 8.12 | Prognostic Value of Albumin-to-Fibrinogen Ratio for 28-Day Mortality among Patients with Sepsis from Various Infection Sites. ( Chang, B; Li, S; Shen, Y; Wang, N, 2022) |
| "This study investigated the prognostic value of the albumin-to-fibrinogen ratio (AFR) in patients with sepsis as a consequence of infection at various sites." | 4.12 | Prognostic Value of Albumin-to-Fibrinogen Ratio for 28-Day Mortality among Patients with Sepsis from Various Infection Sites. ( Chang, B; Li, S; Shen, Y; Wang, N, 2022) |
| "Many global infectious diseases are not well-controlled, underlining a critical need for new, more effective therapies." | 1.51 | Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells. ( Choi, SYC; Gout, PW; Killam, J; Liu, R; Wang, Y; Wong, J; Xu, E, 2019) |
| "Our primary outcome was critical illness, defined as one or more of the composite outcomes of death, vasopressor use or intensive care unit (ICU) admission within 72 hours of presentation." | 1.48 | Comparison of qSOFA with current emergency department tools for screening of patients with sepsis for critical illness. ( Baumann, BM; Darger, B; Fernandez, D; Greenwood, JC; Jung, SY; Kilgannon, JH; Nuckton, TJ; Rodriguez, RM; Shofer, FS; Speich, KG; Troeger, D; Valencia, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, SY | 1 |
| Ryu, S | 1 |
| Oh, SK | 1 |
| Park, JS | 1 |
| You, YH | 1 |
| Jeong, WJ | 1 |
| Cho, YC | 1 |
| Ahn, HJ | 1 |
| Kang, CS | 1 |
| Li, S | 1 |
| Shen, Y | 1 |
| Chang, B | 1 |
| Wang, N | 1 |
| Rodriguez, RM | 1 |
| Greenwood, JC | 1 |
| Nuckton, TJ | 1 |
| Darger, B | 1 |
| Shofer, FS | 1 |
| Troeger, D | 1 |
| Jung, SY | 1 |
| Speich, KG | 1 |
| Valencia, J | 1 |
| Kilgannon, JH | 1 |
| Fernandez, D | 1 |
| Baumann, BM | 1 |
| Wong, J | 1 |
| Choi, SYC | 1 |
| Liu, R | 1 |
| Xu, E | 1 |
| Killam, J | 1 |
| Gout, PW | 1 |
| Wang, Y | 1 |
| MECL, A | 3 |
| PETERA, V | 3 |
| LAHN, V | 3 |
| KUBICEK, J | 2 |
| ZAWISZA-ZENKTELER, W | 1 |
| Bongaerts, GP | 1 |
| van den Heuvel, LP | 1 |
9 other studies available for lactic acid and Communicable Diseases
| Article | Year |
|---|---|
Lactate dehydrogenase to albumin ratio as a prognostic factor for patients with severe infection requiring intensive care.
Topics: Aged; Aged, 80 and over; Albumins; APACHE; Blood Urea Nitrogen; C-Reactive Protein; Communicable Dis | 2021 |
Prognostic Value of Albumin-to-Fibrinogen Ratio for 28-Day Mortality among Patients with Sepsis from Various Infection Sites.
Topics: Albumins; Communicable Diseases; Fibrinogen; Humans; Lactic Acid; Prognosis; Retrospective Studies; | 2022 |
Comparison of qSOFA with current emergency department tools for screening of patients with sepsis for critical illness.
Topics: Adult; Aged; Area Under Curve; Biomarkers; Cohort Studies; Communicable Diseases; Critical Illness; | 2018 |
Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells.
Topics: Aerobiosis; Antimetabolites; Communicable Diseases; Glycolysis; Immune Evasion; Lactic Acid | 2019 |
The influence of physical work upon the lactic acid level in infective hepatitis.
Topics: Communicable Diseases; Hepatitis; Hepatitis A; Lactic Acid; Work | 1954 |
[Method od determination of working capacity in infectious hepatitis; effect of work on lactic acid in the blood and on certain respiratory functions].
Topics: Communicable Diseases; Hepatitis; Hepatitis A; Humans; Lactic Acid; Work | 1954 |
[Studies on a method of determination of working capacity in infectious hepatitis; clinical use of blood lactic acid and of certain respiratory functions following work load in evaluation of convalescence following infectious hepatitis].
Topics: Breath Tests; Communicable Diseases; Convalescence; Hepatitis; Hepatitis A; Humans; Lactic Acid; Res | 1957 |
GLYCOGEN AND LACTIC ACID IN RABBIT'S PERIPHERAL BLOOD IN THE COURSE OF ACUTE STAPHYLOCOCCUS INFECTION.
Topics: Animals; Blood; Communicable Diseases; Glycogen; Lactates; Lactic Acid; Lagomorpha; Rabbits; Researc | 1965 |
Microbial proteinase inside human cells as anti-mitochondrial activity: a new virulence factor in infectious diseases?
Topics: Biological Transport; Carrier Proteins; Communicable Diseases; Endopeptidases; Humans; Hydrolases; I | 2008 |